Regulatory News
UPDATE 1-Dynavax stops development of allergy drug, shares fall
May 16 (Reuters) - Dynavax Technologies Corp said it would stop developing its experimental ragweed allergy drug, Tolamba, after it failed to meet the main goal of a mid-stage clinical trial, sending its shares down more than 7 percent. Full Article
Western majors escape new Kazakh oil export duty
ALMATY, May 16 (Reuters) - The government of Kazakhstan unveiled on Friday a preliminary list of companies subject to a new oil export duty which, as expected, does not include any Western majors. Full Article
Cox Enterprises is buying online advertising firm Adify for at least $300 million -- not a bad multiple on expected 2008 revenues of $35 million. Go to Blog
It is clear to me that the board of directors of Yahoo has acted irrationally and lost the faith of shareholders and Microsoft.
Execs defend humans in high-tech markets
NEW YORK (Reuters) - The heads of the world's biggest stock exchanges agree there is still room for the "human element" in a high-speed trading environment that has aggressively gone electronic. Full Article
